BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1678580)

  • 1. Hemodynamic effects of celiprolol in essential hypertension.
    Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
    Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of celiprolol on systemic and forearm circulation in hypertensive patients: a double-blind cross-over study versus metoprolol.
    Trimarco B; Lembo G; De Luca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Clin Pharmacol; 1987 Aug; 27(8):593-600. PubMed ID: 2888795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central and peripheral hemodynamics of celiprolol.
    Mancia G
    Am Heart J; 1988 Nov; 116(5 Pt 2):1405-11. PubMed ID: 2903651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.
    Silke B; Rosenthal F; Taylor S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S122-6. PubMed ID: 2427841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
    van Zyl AI; Jennings AA; Bateman ED; Opie LH
    Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term systemic hemodynamic adaptation to beta-adrenergic inhibition with atenolol in hypertensive patients.
    Simon G; Franciosa JA; Gimenez HJ; Cohn JN
    Hypertension; 1981; 3(2):262-8. PubMed ID: 6111532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
    Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
    Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study.
    Stumpe K; Kolloch R; Mathieu M; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():73-5. PubMed ID: 2864069
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of celiprolol and atenolol in the treatment of hypertension.
    Rosenthal F; Silke B; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():76-7. PubMed ID: 2864070
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Lamon KD
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1291-5. PubMed ID: 1672605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.